BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11642245)

  • 21. Lead poisoning from a retained bullet: a case report and review.
    Khurana V; Bradley TP
    J Assoc Acad Minor Phys; 1999; 10(2):48-9. PubMed ID: 10826009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral chelators for childhood lead poisoning.
    Liebelt EL; Shannon MW
    Pediatr Ann; 1994 Nov; 23(11):616-9, 623-6. PubMed ID: 7838614
    [No Abstract]   [Full Text] [Related]  

  • 23. Unanswered questions in metal chelation.
    Kosnett MJ
    J Toxicol Clin Toxicol; 1992; 30(4):529-47. PubMed ID: 1331492
    [No Abstract]   [Full Text] [Related]  

  • 24. [2,3-dimercaptosuccinic acid: a new chelating agent, safe and efficacious, for lead poisoning].
    Nogué S; Sanz-Gallén P; Munné P; To-Figueras J
    Med Clin (Barc); 1993 Oct; 101(12):478-9. PubMed ID: 8231377
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombocytosis secondary to chronic lead poisoning.
    Al Momen A
    Platelets; 2010; 21(4):297-9. PubMed ID: 20196630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals.
    Goyer RA; Cherian MG; Jones MM; Reigart JR
    Environ Health Perspect; 1995 Nov; 103(11):1048-52. PubMed ID: 8605855
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ambulatory treatment for lead poisoning].
    Otermin Maia I; Belzunce Elizalde M
    An Med Interna; 2002 Aug; 19(8):440-1. PubMed ID: 12244800
    [No Abstract]   [Full Text] [Related]  

  • 28. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scientific basis for chelation: animal studies and lead chelation.
    Smith D; Strupp BJ
    J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric management problems. Lead poisoning.
    Agruss JC;
    Pediatr Nurs; 2001; 27(6):611-2. PubMed ID: 12024536
    [No Abstract]   [Full Text] [Related]  

  • 31. Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats.
    Beaudin SA; Stangle DE; Smith DR; Levitsky DA; Strupp BJ
    Neurotoxicol Teratol; 2007; 29(2):188-202. PubMed ID: 17196787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficiency of succimer used with calcium and ascorbic acid in the treatment of mild lead-poisoning.
    Jin Y; Yu F; Liao Y; Liu S; Liu M; Xu J; Yang J
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):137-42. PubMed ID: 21787678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic lead toxicity with succimer: a case series of 2 adults with retained lead shotgun fragments.
    Cyrus RM; Woller SC; Stevens MH; Pugh MR; Stevens SM; Edwards CQ
    Am J Forensic Med Pathol; 2011 Sep; 32(3):236-8. PubMed ID: 21512379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers.
    Paediatr Perinat Epidemiol; 1998 Jul; 12(3):313-33. PubMed ID: 9690266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constipation.
    Smith LL
    Clin Pediatr (Phila); 2007 Jan; 46(1):83-4. PubMed ID: 17164517
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lead poisoning treatment--a continuing need (commentary).
    Shannon M
    J Toxicol Clin Toxicol; 2001; 39(7):661-3. PubMed ID: 11778663
    [No Abstract]   [Full Text] [Related]  

  • 40. DMSA.
    Altern Med Rev; 2000 Jun; 5(3):264-7. PubMed ID: 10869106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.